Zacks Investment Research on MSN
Investors heavily search UiPath, Inc. (PATH): Here is what you need to know
UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Shares of UiPath (NYSE:PATH) fell 20% to record low on Thursday after the software company forecast revenue for the full-year fiscal 2026 below market expectations, citing "significant increase in ...
Zacks Investment Research on MSN
UiPath (PATH) stock sinks as market gains: Here's why
UiPath (PATH) closed the most recent trading day at $10.94, moving -3.36% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.1%. Meanwhile, the Dow ...
UiPath (NYSE:PATH) shares sank 15.85% to $9.96 on Thursday, hitting a record low after the company's fiscal 2026 revenue forecast fell short of expectations. The automation software provider expects ...
UiPath (PATH) closed at $11.70 in the latest trading session, marking a -9.69% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.01% for the day. On the other ...
UiPath is well-positioned in the fast-growing agentic AI market, with its enhanced cross-vendor orchestration capabilities.
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results